Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC)
Economopoulou, P Spathas, NS Papaxoinis, Georgios Anastasiou, M Gkotzamanidou, M Kotsantis, I Gavrielatou, N Oikonomopoulos, N Kirodimos, E Vagia, EM
Economopoulou, P
Spathas, NS
Papaxoinis, Georgios
Anastasiou, M
Gkotzamanidou, M
Kotsantis, I
Gavrielatou, N
Oikonomopoulos, N
Kirodimos, E
Vagia, EM
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Economopoulou P, Spathas NS, Papaxoinis G, Anastasiou M, Gkotzamanidou M, Kotsantis I, et al. Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC). J Clin Oncol. 2019;37(15_suppl):6034-.